SKScott H. Koeneman

Scott H. Koeneman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Scott H. Koeneman has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database

    by Lawrence Chiang, Adam Bodzin, Daniel Lin, Nader Hanna, Scott Koeneman, Hien Dang, Charles J. Yeo, Christopher Shubert, Richard Zheng

    Background: Effects of neoadjuvant immunotherapy (NIT) before liver resection are not well-described in hepatocellular carcinoma (HCC). Survival and R0 resection rates in HCC patients undergoing curative-intent resection with or without NIT were evaluated. Methods: A retrospective study of stage I-III HCC patients undergoing hepatectomy from the 2017–2022 National Cancer Database was performed. Patients receiving NIT were exactly matched 1:3 to non-NIT patients by clinical stage. Primary outcomes were margin positivity, 30- and 90-day mortality, and overall survival. Results: After matching 510 patients, 97 received NIT and 291 did not (non-NIT). Resections included segmental (178, 45.9%), lobar (149, 38.4%), and extended hepatectomy (61, 15.7%). The NIT group included ablation (6, 6.2%), radiation (25, 25.8%), and Y90 (18, 18.6%). The non-NIT group included 124 (42.6%) chemotherapy, 23 (7.9%) chemotherapy plus ablation, 31 (10.7%) chemotherapy plus radiation, four (1.4%) radiation, and 109 (37.5%) upfront surgery. NIT patients were treated more at high-volume (41.2% vs. 0%) and academic/research centers (85.4% vs. 50.5%). NIT R0 resection rates were higher (97.9% vs. 93.2%, p = 0.009). Median survival was higher in the NIT group (59.1 vs. 50.4 months, p = 0.002); 30- and 90-day mortality were similar. NIT was not independently associated with improved survival in multivariable Cox regression (HR 0.73, 95% CI [0.35, 1.55]), although the effect estimate indicates a protective effect may be present. Conclusions: NIT was associated with higher R0 resection rates and overall survival without increasing short-term mortality in selected patients at high-volume academic centers, but was not independently associated with survival when adjusting for confounders. As we continue to see increasing use of immunotherapy in the neoadjuvant setting, these findings should be considered hypothesis-generating and warrant prospective validation before widespread adoption for HCC.

  • The Impact of Failed Deceased Donor Kidney Graft Longevity on Mortality

    by William A. Preston, Scott H. Koeneman, Mia N. Brownfield, Devon J. Pace, Haley Kittle, Khaled Noueihed, Peter Altshuler, Adam M. Frank, Jaime M. Glorioso, Carlo Ramirez, et al.

    Introduction: While the benefits of deceased donor kidney transplant versus dialysis are clear, the impact of graft longevity remains unclear. Research Questions: This study assessed survival between patients with failed grafts and patients who remained on dialysis alone. Design: Utilizing the Organ Procurement and Transplant Network database, adults on dialysis listed for deceased donor kidney transplant between 1/2005 and 12/2017 were identified ( n = 265 280; n = 129 062 [48.7%] transplant; n = 136 218 [51.3%] dialysis alone, not transplanted). A multivariable Cox proportional hazards model incorporating confounding covariates and utilizing transplant status (dialysis alone, functioning graft, failed graft) as a time-varying covariate was constructed. Representative patients were then fit to this model to assess survival probability. Results: Patients who underwent transplant experienced a 65% reduction in mortality compared to those remaining on dialysis. However, graft failure ( n = 19 389, 15.0% of transplants) was associated with a 47% increase in hazard rate compared to dialysis. When an average-risk patient was fit to this model, with transplant 4 years after dialysis initiation, a graft required longevity of 3 years to convey a survival probability benefit at 5 years postoperatively (9 years from waitlisting, 35%) over remaining on dialysis through the same time point (9 years from waitlisting, 32%). Conclusions: These results argue for scrutiny of anticipated graft longevity and its expected impact on individual outcomes and advocate for 3-year graft survival as a critical clinical measure for transplant programs.

  • Open Access

    A novel bootstrap goodness-of-fit test for normal linear regression models

    by Scott H. Koeneman, Joseph E. Cavanaugh

    In this work, the distributional properties of the goodness-of-fit term in likelihood-based information criteria are explored. These properties are then leveraged to construct a novel goodness-of-fit test for normal linear regression models that relies on a nonparametric bootstrap. Several simulation studies are performed to investigate the properties and efficacy of the developed procedure, with these studies demonstrating that the bootstrap test offers distinct advantages as compared to other methods of assessing the goodness-of-fit of a normal linear regression model. Our inferential technique can be employed using the R package, available freely via the Comprehensive R Archive Network.


  • Open Access

    A New Bootstrap Goodness-of-Fit Test for Normal Linear Regression Models

    by Scott H. Koeneman, Joseph E. Cavanaugh

    In this work, the distributional properties of the goodness-of-fit term in likelihood-based information criteria are explored. These properties are then leveraged to construct a novel goodness-of-fit test for normal linear regression models that relies on a non-parametric bootstrap. Several simulation studies are performed to investigate the properties and efficacy of the developed procedure, with these studies demonstrating that the bootstrap test offers distinct advantages as compared to other methods of assessing the goodness-of-fit of a normal linear regression model.

  • Open Access

    Frequency and Duration of, and Risk Factors for, Diagnostic Delays Associated with Histoplasmosis

    by Aaron C. Miller, Alan T. Arakkal, Scott H. Koeneman, Joseph E. Cavanaugh, George R. Thompson, John W. Baddley, Philip M. Polgreen

    Histoplasmosis is often confused with other diseases leading to diagnostic delays. We estimated the incidence, length of, and risk factors for, diagnostic delays associated with histoplasmosis. Using data from IBM Marketscan, 2001–2017, we found all patients with a histoplasmosis diagnosis. We calculated the number of visits that occurred prior to the histoplasmosis diagnosis and the number of visits with symptomatically similar diagnoses (SSDs). Next, we estimated the number of visits that represented a delay using a simulation-based approach. We also computed the number of potential opportunities for diagnosis that were missed for each patient and the length of time between the first opportunity and the diagnosis. Finally, we identified risk factors for diagnostic delays using a logistic regression model. The number of SSD-related visits increased significantly in the 97 days prior to the histoplasmosis diagnosis. During this period, 97.4% of patients had a visit, and 90.1% had at least one SSD visit. We estimate that 82.9% of patients with histoplasmosis experienced at least one missed diagnostic opportunity. The average delay was 39.5 days with an average of 4.0 missed opportunities. Risk factors for diagnostic delays included prior antibiotic use, history of other pulmonary diseases, and emergency department and outpatient visits, especially during weekends. New diagnostic approaches for histoplasmosis are needed.


  • Open Access

    Diurnal Temperature Variation and Using Fever to Screen for Infectious Diseases

    by Aaron C. Miller, Scott Koeneman, Philip M. Polgreen

    Fevers have been used as marker of disease state for hundreds of years and are frequently used to screen for infectious diseases during infectious disease outbreaks. However, body temperature and fevers have been shown to vary over the course of a day and across individuals by age, sex and other characteristics. The objective of this paper is to describe the individual variation in diurnal temperature patterns during episodes of febrile activity using a database of millions of recorded temperatures across the United States. We then model the probability of recording a fever during a single reading at given time for individuals who are experiencing a febrile episode. We find a wide variation in body temperatures over the course of a day and across individual characteristics. Similarly, the likelihood of recording a fever may vary widely by the time of day when the reading is taken and by an individual’s age or sex. These results suggest diurnal temperature variation and demographics should be considered when using body temperature to screen for disease, especially for diseases that are contagious.